We are live on ! Find out more
SCP

Shorepoint Capital Partners Portfolio holdings

AUM $503M
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$175M
AUM Growth
-$1.38M
Cap. Flow
-$5.75M
Cap. Flow %
-3.28%
Top 10 Hldgs %
31.53%
Holding
90
New
4
Increased
17
Reduced
60
Closed
3

Top Sells

Rank Stock Value
1
AMP icon
Ameriprise Financial
AMP
+$949K
2
AAPL icon
Apple
AAPL
+$777K
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$772K
4
KHC icon
Kraft Heinz
KHC
+$634K
5
VFC icon
VF Corp
VFC
+$503K

Sector Composition

Rank Sector Weight
1 Healthcare 18.41%
2 Financials 11.09%
3 Technology 10.86%
4 Industrials 8.15%
5 Consumer Discretionary 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYG
1
Tortoise Energy Infrastructure Corp
TYG
$1.11B
$9.3M 5.3%
103,088
+2,796
+3% +$258K
SCHD icon
2
Schwab US Dividend Equity ETF
SCHD
$101B
$7.59M 4.33%
428,820
-21,201
-5% -$373K
ABBV icon
3
AbbVie
ABBV
$450B
$6.78M 3.87%
93,216
+6,123
+7% +$481K
JNJ icon
4
Johnson & Johnson
JNJ
$609B
$5.29M 3.02%
37,971
-2,775
-7% -$384K
SCHG icon
5
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$4.98M 2.84%
479,152
-40,032
-8% -$407K
AAPL icon
6
Apple
AAPL
$4.9T
$4.81M 2.74%
97,236
-15,940
-14% -$777K
JPM icon
7
JPMorgan Chase
JPM
$907B
$4.61M 2.63%
41,185
-3,715
-8% -$410K
CVS icon
8
CVS Health
CVS
$137B
$4.2M 2.39%
76,995
-7,121
-8% -$383K
VFC icon
9
VF Corp
VFC
$6.66B
$4.15M 2.36%
47,474
-5,838
-11% -$503K
QCOM icon
10
Qualcomm
QCOM
$181B
$3.59M 2.05%
47,241
-4,257
-8% -$312K
VLO icon
11
Valero Energy
VLO
$91.9B
$3.37M 1.92%
39,381
-425
-1% -$35.1K
CCL icon
12
Carnival Corporation Ltd
CCL
$36.2B
$3.28M 1.87%
70,533
+5,530
+9% +$289K
AVGO icon
13
Broadcom
AVGO
$1.76T
$3.19M 1.82%
110,790
-2,580
-2% -$75.2K
PEP icon
14
PepsiCo
PEP
$187B
$3.19M 1.82%
24,289
-1,215
-5% -$156K
SCHA icon
15
Schwab U.S Small- Cap ETF
SCHA
$22.6B
$3.18M 1.81%
178,052
-10,880
-6% -$192K
MRK icon
16
Merck
MRK
$315B
$3.16M 1.8%
39,513
-2,599
-6% -$199K
MCD icon
17
McDonald's
MCD
$190B
$3.14M 1.79%
15,110
-1,003
-6% -$199K
ABT icon
18
Abbott
ABT
$175B
$3.12M 1.78%
37,046
+32
+0.1% +$2.52K
RTX icon
19
RTX Corp
RTX
$261B
$3.08M 1.76%
37,577
-222
-0.6% -$18.6K
VTR icon
20
Ventas
VTR
$46.7B
$3.03M 1.73%
44,350
-3,016
-6% -$192K
VZ icon
21
Verizon
VZ
$182B
$3.01M 1.72%
52,658
-1,582
-3% -$91.2K
CSCO icon
22
Cisco
CSCO
$441B
$2.94M 1.68%
53,814
-4,527
-8% -$250K
CMCSA icon
23
Comcast
CMCSA
$85B
$2.85M 1.62%
67,322
-4,365
-6% -$184K
MSFT icon
24
Microsoft
MSFT
$2.93T
$2.66M 1.52%
19,880
-3,895
-16% -$494K
OXY icon
25
Occidental Petroleum
OXY
$54.6B
$2.54M 1.45%
50,566
+12,722
+34% +$716K

Similar funds

Shorepoint Capital Partners's Q2 2019 Portfolio in Review

As of Q2 2019, Shorepoint Capital Partners held 90 positions worth $175M, down 0.78% from $177M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Shorepoint Capital Partners withdrew a net $5.75M in Q2 2019, closing 3 positions and reducing 60 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $772K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Financials and Technology.

Against the trend, Shorepoint Capital Partners opened a new position in Calamos Convertible Opportunities and Income Fund worth $840K.

  • Shorepoint Capital Partners's largest Q2 2019 buy was Calamos Convertible Opportunities and Income Fund: 80,000 shares worth $840K.
  • Shorepoint Capital Partners added most to Occidental Petroleum in Q2 2019, an estimated $716K increase.
  • Shorepoint Capital Partners's biggest Q2 2019 reduction was Ameriprise Financial, cutting an estimated $949K.
  • Shorepoint Capital Partners fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $772K.
  • Shorepoint Capital Partners's ten largest holdings make up 32% of its $175M portfolio in Q2 2019.
  • Shorepoint Capital Partners opened 4 new positions and closed 3 in Q2 2019.
  • Shorepoint Capital Partners's portfolio value fell 0.78% quarter-over-quarter to $175M.

Based on Shorepoint Capital Partners's 13F filing for Q2 2019, filed 14 Aug 2019.